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Dietary InsP6 can modulate eukaryotic cell prolifera-
tion and has complex nutritive consequences, but its
metabolism in the mammalian gastrointestinal tract
is poorly understood. Therefore, we performed
phylogenetic analyses of the gastrointestinal micro-
biome in order to search for candidate InsP6
phosphatases. We determined that prominent gut
bacteria express homologs of the mammalian InsP6
phosphatase (MINPP) and characterized the enzyme
from Bacteroides thetaiotaomicron (BtMinpp). We
show that BtMinpp has exceptionally high catalytic
activity, which we rationalize on the basis of muta-
genesis studies and by determining its crystal
structure at 1.9 A˚ resolution. We demonstrate that
BtMinpp is packaged inside outer membrane vesi-
cles (OMVs) protecting the enzyme from degradation
by gastrointestinal proteases. Moreover, we uncover
an example of cross-kingdom cell-to-cell signaling,
showing that the BtMinpp-OMVs interact with intes-
tinal epithelial cells to promote intracellular Ca2+
signaling. Our characterization of BtMinpp offers
several directions for understanding how the micro-
biome serves human gastrointestinal physiology.INTRODUCTION
The adult human gastrointestinal (GI) tract accommodates a
bacterial community that comprises trillions of cells. This micro-
biota has many essential roles in human health (Tremaroli and
Ba¨ckhed, 2012): it suppresses proliferation of pathogenic
microbes and has important nutritional consequences, including
vitamin synthesis and fermentation of complex dietary carbohy-
drates. Microbial metabolites also regulate the signaling activ-646 Cell Reports 6, 646–656, February 27, 2014 ª2014 The Authorsities of the host’s intestinal epithelium, which, for example, aids
the development and maintenance of local immune responses.
Thus, considerable efforts are now being made to determine
the precise nature of the dialog between gut bacteria and the
human host. Much of the previous work in this area has focused
on the roles of diffusible, small-molecule hormones and nutri-
ents. We now describe a vehicle produced by a prevalent
gut bacterium, Bacteroides thetaiotaomicron (Bt): a vesicle-
enclosed homolog of a mammalian cell-signaling InsP6 phos-
phatase, MINPP.
Enzymatic homeostasis of InsP6 levels in the gut can have far-
reaching consequences for human health. Considerable quanti-
ties of InsP6 are ingested daily as it is the primary storage form of
phosphorus in cereals and legumes (Kumar et al., 2010). InsP6 is
therefore a source of inositol and phosphate, two vital nutrients.
However, InsP6 is also considered to have antinutritive proper-
ties, given that it inhibits polysaccharide digestibility and che-
lates divalent cations, thereby limiting their bioavailability in the
GI tract (Kumar et al., 2010). More recently, with the emergence
of cell-signaling activities for InsP6 and other members of the
inositol phosphate family, dietary InsP6 has received separate
attention for its anticarcinogenic properties (Fox and Eberl,
2002; Vucenik and Shamsuddin, 2003), at least when present
at high concentrations. Conversely, lower concentrations of
InsP6 may stimulate tumor cell proliferation (Windhorst et al.,
2013). In any case, exogenous InsP6 can enter cells and be
metabolized (Windhorst et al., 2013), thereby potentially contrib-
uting to intracellular signaling processes in intestinal epithelial
and immune cells. For example, InsP6 is the precursor for inositol
pyrophosphates, which have pleiotropic functions including the
regulation of energy metabolism (Szijgyarto et al., 2011), insulin
sensitivity (Chakraborty et al., 2010), and bactericidal activities
of immune cells (Prasad et al., 2011).
Humans and other monogastric animals lack enzymes
capable of participating in dietary InsP6 homeostasis, relying
instead on exogenous phosphatases provided by resident
microbes (Haros et al., 2007; Steer et al., 2004). Surprisingly,
the nature of the genes that encode these phosphatases
Figure 1. Mutation of Active Site Residues Alters the Specificity of
Initial Attack on InsP6 Substrate
(A–C) Products of reaction of native BtMinpp- (A), A31Y- (B), and R183D- (C)
substituted enzyme with myo-inositol(1,[32P]2,3,4,5,6)P6 were resolved by
Partisphere SAX HPLC.Mutated proteins were incubated at a concentration of
2.5 mg/ml and native protein at 0.25 mg/ml, with 1 mM InsP6. The regions of the
chromatogram in which InsP3, InsP4, and specific InsP5 isomers elute are
indicated in (A). For native enzyme (inset in A), reaction products were mixed
with standards of myo-[2-3H]inositol (1,3,4,5,6)P5 (InsP5 [2-OH]), D/L- myo-
[2-3H]inositol (1,2,4,5,6)P5 (InsP5 [1/3-OH]), and D/L- myo-[2-
3H]inositol
(1,2,3,4,5)P5 (InsP5 [4/6-OH]). Fractions, 0.25 min, were collected and radio-
activity was estimated by scintillation counting; 3H, open circles; 32P, filled
circles. For R183D-substituted enzyme (inset in C), the reaction products were
additionally mixed with standards of myo-[14C]InsP5 [2-OH] and D/L- myo-
[14C]InsP5 [1/3-OH] and resolved on a Adsorbosphere SAX HPLC column. This
column separates InsP5 [2-OH] from InsP5 [1/3-OH]. Fractions, 0.25 min, were
collected and radioactivity estimated by scintillation counting: 14C, open
squares; 32P, filled circles.
Cis unknown for virtually the entire microbiome of the human GI
tract, although they are generally assumed to be ‘‘phytases’’
(Haefner et al., 2005; Steer et al., 2004; Tamayo-Ramos et al.,
2012). Such enzymes occur in a number of environmental niches
in which they scavenge inorganic phosphate from InsP6, but they
have no signaling function. Moreover, if phytases were to be
secreted into the GI tract, it is unclear how they might access
dietary InsP6 while avoiding digestive proteases. In the current
study, our phylogenetic, biochemical, and structural character-
ization of BtMinpp characterizes an unexpected repertoire of
widely distributed and highly active class of InsP6 phosphatases
in the GI tract.
RESULTS
B. thetaiotaomicron Express a Homolog of a Mammalian
Inositol Phosphate Signaling Phosphatase
The Bacteroidetes are a dominant constituent of the mammalian
GI tract microbiota. The genome ofB. thetaiotaomicron (Xu et al.,
2003) contains a gene,BT_4744, which has a primary annotation
(Hidden Markov Models-based annotation) as encoding a puta-
tive multiple inositol-polyphosphate phosphatase (MINPP, EC
3.1.3.62). This is a notable observation because bacteria have
not previously been suggested to utilize the inositol phosphate
signaling cascade (Michell, 2008). Indeed, MINPPs have only
previously been considered to function inside animal cells,
mainly by regulating levels of InsP5 and InsP6 (Chi et al., 2000;
Romano et al., 1998). Strikingly, BT_4744 shares no significant
sequence similarity with the bacterial or fungal phytases
described in the literature (see Table S1). We shall refer to the
BT_4744-encoded enzyme as BtMinpp, and below we further
justify this characterization.
High-performance liquid chromatography (HPLC) analysis of
the catalytic activity of a His-tagged recombinant form of
BtMinpp confirmed that this protein has InsP6 phosphatase
activity (Figure 1A). The Vmax value for InsP6 (178 mmol/mg/min;
Table S2) is the highest yet reported for any member of the
MINPP family, being several orders of magnitude greater than
that for the human (0.006 mmol/mg/min) and avian (0.7 mmol/
mg/min) representatives (Ali et al., 1995; Cho et al., 2006).
We incubated BtMinpp with Ins(1,[32P]2,3,4,5,6)P6 substrate
and identified the InsP5 products from their HPLC elution posi-
tions relative to myo-[2-3H]InsP5 standards (Figure 1A, inset).
Although Ins(1,3,4,5,6)P5 (InsP5 [2-OH]) cannot be detected
using Ins(1,[32P]2,3,4,5,6)P6 as substrate, we can be confident
that InsP5 [2-OH] is not a major product because of the retention
of radiolabel in progressively less-phosphorylated products,
InsP4, InsP3, and InsP2 (Figure S1C). In any case, the use
of Ins(1,[32P]2,3,4,5,6)P6 as substrate revealed that multiple
InsP5 products were formed by BtMinpp, including D-and/or
L-Ins(1,2,3,4,5)P5 (InsP5 [4/6-OH]), Ins(1,2,3,4,6)P5 (InsP5
[5-OH]), and D-and/or L-Ins(1,2,4,5,6)P5 (InsP5 [1/3-OH]) (Fig-
ure S2). Such a lack of specificity toward the site of initial attack
on InsP6 is a defining characteristic of MINPPs of both plants
(Dionisio et al., 2007) and animals (Figure S1A; Ali et al., 1995;
Craxton et al., 1997). This catalytic flexibility contrasts with the
more precise positional specificity of phytases. In fact, the
distinct specificities of different types of phytases are sufficientell Reports 6, 646–656, February 27, 2014 ª2014 The Authors 647
Table 1. X-Ray Data Collection and Structure Refinement
Statistics
SAD Data Phosphatea InsS6
a
Data Collection
Wavelength (A˚) 0.9799 0.9778 0.9778
Space group P 21 P 21 P 21
Cell parameters
















c 0.098 (0.265) 0.048 (0.473) 0.069 (0.529)
<(I)/sd(I) > 16.4 (7.3) 12.6 (2.1) 10.5 (2.9)
Completeness (%) 100.0 (100.0) 97.1 (97.0) 99.2 (99.2)
Multiplicity 7.4 (7.5) 2.3 (2.4) 3.3 (3.2)
Anomalous
completeness (%)
99.9 (100.0) — —











Water molecules 451 127
Rcryst
d (%) 16.6 (23.5) 15.6 (19.7)
Rfree
e (%) 21.3 (28.2) 21.7 (27.0)
Ramachandran analysis (%)
Most favored 97.58 97.37
Outliers 0.25 0.25
Rmsds
Bonds, A˚ 0.007 0.008
Angles,  0.976 1.17




aPhosphate and IHS refer to the complexes of BtMinpp with inorganic
phosphate and myo-inositol hexakis sulfate, respectively.
bFigures in brackets refer to the high resolution data bin as indicated.
cRsym = SrIi - hIir/ S Ii where hIi is the average of symmetry equivalent re-
flections and the summation extends over all observations for all unique
reflections.
dRcryst =SrrFor-rFcrr/SrForwhere Fo and Fc are themeasured and calcu-
lated structure factors, respectively
eFor Rfree the summations extends over a randomly selected subset (5%)
of reflections excluded from all stages of refinementto serve as a classification system: there are 3-phytases (E.C.
3.1.3.8) (see also Figure S1B), 6-phytases (E.C. 3.1.3.26), and
5-phytases (E.C. 3.1.3.72).
Although mammalian MINPPs exhibit positional promiscuity
toward InsP6 (Craxton et al., 1997), these enzymes are highly
specific toward certain other inositol phosphate substrates.648 Cell Reports 6, 646–656, February 27, 2014 ª2014 The AuthorsFor example, they primarily remove the 3-phosphate from
Ins(1,3,4,5,6)P5 and Ins(1,3,4,5)P4 (Craxton et al., 1997) and
display a considerably higher Vmax toward Ins(1,3,4,5)P4 sub-
strate than to InsP6 (Nogimori et al., 1991). The Bacteroides
enzyme shares with mammalian MINPPs increased catalytic
activity toward Ins(1,3,4,5)P4 substrate (Figure S2A), yielding
a Vmax value 20- to 36-fold higher than that obtained with
InsP6 (Table S2). In contrast, incubation of BtMinpp with
Ins(1,3,4,5)P4 (Figure S2A) yielded two InsP3 peaks that coeluted
with Ins(1,4,5)P3 and Ins(1,3,4)P3 standards. The pH optima of
2.5, 4.0, and 7.5 (Figure S3) overlaps with the pH profile of the
human GI tract (Fallingborg, 1999), consistent with the success-
ful adaptation of BtMinpp to this environment.
The Crystal Structure of BtMinpp in Complex with a
Substrate Analog
There is no published description of the structures of any mem-
bers of the MINPP family. The crystal structure (diffraction data
were collected on beamlines I02 and I24 at the Diamond Light
Source, UK) of BtMinpp expressed in Escherichia coli as an
N-terminal 6 3 His fusion protein was solved at pH 5.0 by SAD
using phases from a selenomethionyl derivative. Refinement
against native data at 1.93 A˚ resolution gave a final structural
model with an Rcryst of 16.6% (Rfree 21.3%) and excellent geom-
etry. A single inorganic phosphate group is bound at the active
sites of both molecular copies of BtMinpp in the crystallographic
asymmetric unit, presumably scavenged from the phosphate
buffer used during purification of the enzyme (Table 1; Figure S4).
A second structure was solved by difference Fourier analysis at
2.42 A˚ resolution in which the inorganic phosphate ions are
displaced by the nonhydrolysable InsP6 analog, myo-inositol
hexakissulfate (InsS6), again bound in the active sites of both
molecules (Rcryst 15.6%; Rfree 21.7%) (Figure 2; Table 1). Com-
parison of the structures of analog- and phosphate-bound forms
revealed an rmsd of 0.20 A˚ for Ca atoms suggesting limited
conformational changes occur between the two states.
BtMinpp folds into two domains, an a/b domain and an a
domain. Despite their low amino acid sequence homology, and
functional diversity, all available crystal structures of members
of branch 2 of the histidine phosphatase superfamily possess
this general domain arrangement with a structurally conserved
a/b domain (the ‘‘core’’ domain) and a more variable a-domain
(the ‘‘cap’’ domain) (Rigden, 2008). The cleft between the two
domains always contains the active site, which is highly special-
ized in each of the distinct branch two subfamilies, allowing them
to perform different functions. The active site in BtMinpp is lined
with predominantly basic amino acids, thereby rationalizing how
the enzyme can bind unusually highly phosphorylated substrates
such as InsP6 (Figure 3A). InsS6 is bound in the active site with its
3-sulfate group occupying the position taken by inorganic phos-
phate in the enzyme-phosphate complex and presumably that of
the hydrolyzed phosphate group in substrates. This conclusion
is consistent with the sulfur atom of this group lying 3.1 A˚ from
the imidazole Nε2 atom of the side chain of H59. By analogy
with other members of the superfamily, we predict that H59 of
BtMinpp acts as a nucleophile during catalysis to generate a
phosphohistidine intermediate. In phytases, the aspartate resi-
due from a proximal HD sequence motif takes the role of proton
Figure 2. Simulated Annealing Omit Map Revealing the Location of
InsS6 Bound to the Active Site of BtMinpp
A region of the simulated annealing omit electron density map (gray lines)
(Bru¨nger and Rice, 1997) calculated with data to a resolution of 2.42 A˚ and
contoured at 1.8 s. Selected active site residues are shown in stick repre-
sentation and labeled. The location of the inhibitor in the final refined structure
of the complex is shown superimposed on the omit map electron density.donor for the leaving group (Kostrewa et al., 1997). However, a
distinguishing feature of mammalian and plant MINPPs is the
substitution of this motif with an HAE tripeptide in which the glu-
tamic acid residue (E325 in BtMinpp) is the candidate proton
donor. Indeed, in our crystal complex with InsS6 one of the
E325 side-chain carboxyl oxygen atoms is only 3.3 A˚ from the
ether oxygen bridging the 3-sulfate to the inositol ring, the analog
to the phosphate-leaving group in InsP6.
The structure of the InsS6-protein crystal complex rationalizes
the ability of BtMinpp to remove the 3-phosphate from its natural
substrate, InsP6. However, BtMinpp also removes alternative
phosphates from InsP6 (Figure 1A), indicating that the enzyme’s
active site can bind substrate in alternate orientations. To
analyze which features of the catalytic core of BtMinpp permit
this positional promiscuity, we compared its structure with that
of A. niger PhyA phytase (Oakley, 2010), a member of a different
subfamily of clade 2 histidine acid phosphatases, that hydro-
lyzes InsP6 by specific removal of its 3-phosphate (as does the
closely related A. ficuum PhyA; Figure S2B). A comparison of
this PhyA with BtMinpp yielded an rmsd of 2.5 A˚, albeit with
low sequence identity (16% over 360 structurally equivalent res-
idues; Table S3). The overall topologies of these two enzymes
are superficially similar, which is why we have labeled those sec-
ondary structural elements in BtMinpp that correspond to those
found in PhyA (Figures 3A and S5).
Accordingly, we performed an overlay of the InsS6-bound
structures of BtMinpp and A. niger phytase based on the coordi-
nates of the backbone atoms of the active site fingerprintCsequence (RHGXRXP; residues 58–64 in BtMinpp) found in the
A-a loop and those of the short region containing the presumed
proton donor, E325 (HAE; residues 323–325) from the N-terminal
region of helix l. The rmsd was 0.30 A˚ for these 30 atoms. The
conformations of InsS6 were very similar (rmsd 0.50 A˚ for the
six inositol ring carbon atoms) in these overlayed structures.
Nevertheless, this superposition (Figure 3B) revealed some sig-
nificant differences in the nature of the ligand-binding residues
in the two proteins. Binding pocket S2 shows the most extensive
differences. Here, R183, conserved in MINPP enzymes and
forming an ion pair with the 2-sulfate of the ligand, replaces the
Asp in PhyA. Additionally, the HAE tripeptide of BtMinpp re-
places the characteristic HD sequence motif in PhyA. Both sub-
stitutions substantially alter the volume and character of S2. The
substitution of the phytase proton donor (Asp) with Ala324 in
BtMinpp increases volume and decreases polarity of both S2
and the adjacent S4 pockets. Finally, a tyrosine residue that con-
tributes to pockets S4 and S5 is replaced by Ala31in BtMinpp.
These substitutions at positions 31 and 324 make the S4 and
S5 pockets of BtMinpp significantly larger than those in PhyA.
The significance of the larger BtMinpp ligand-binding site is
that it may permit alternate substrate binding modes. Molecular
docking experiments further support the concept of a reduced
discrimination against alternative InsP6-binding modes in
BtMinpp compared to PhyA (Figure 3C; Table S4): PhyA showed
an exclusive preference for a limited set of highly similar InsP6
binding modes all presenting the D-3 phosphate in binding
pocket S3. Termed the obverse binding mode, this places the
D-2 axial phosphate in the S2 binding pocket. BtMinpp was
more permissive, allowing binding of not only the D-3 phosphate
in pocket S3 but also the D-5 and D-6 phosphates. These addi-
tional binding modes present equatorial phosphates of InsP6 in
the S2 pocket and are distributed between obverse and reverse
presentations (the latter having the inositol ring flipped over to
present its opposite face to the enzyme). Given that the A31Y
and R183D substitutions in phyA relative to BtMinpp were iden-
tified by our structural studies as making particularly significant
contributions to the volume and polarity of the active site, we
tested that hypothesis with a mutagenic approach.
Impact of Mutating the Active Site of BtMinpp on the
Specificity of Initial Attack on InsP6 Substrate
When incubated with InsP6, the A31Ymutant of BtMinpp yielded
an HPLC profile of InsP5 products (Figure 1B) very similar to that
observed for wild-type enzyme (Figure 1A). Thus, the positional
specificity toward InsP6 was not affected by this mutation.
Nevertheless, it should be noted that the HPLC profile of the
wild-type enzyme was obtained with one-tenth the protein con-
centration of that of the A31Y mutant (we estimated that the
A31Y mutant was approximately 2.5-fold less active). Elevating
the wild-type enzyme concentration 10-fold resulted in complete
dephosphorylation of InsP5 and InsP6 (Figure S2B). Remarkably,
the R183D substitution abolished the production of InsP5 [4/6-
OH], but retained a peak with the retention time of InsP5
[5-OH]/ InsP5 [1/3-OH] (Figure 1C). Using an Adsorbosphere
SAX column to resolve InsP5 [5-OH] from InsP5 [1/3-OH] and
InsP5 [2-OH], we confirmed that the R183D mutant had lost the
ability to attack the 4/6-position (compare Figures 1A and 1C),ell Reports 6, 646–656, February 27, 2014 ª2014 The Authors 649
Figure 3. X-Ray Crystal Structure of the
BtMinpp
(A) Cylinder and ribbon diagram showing a
superposition of the crystal structures of BtMinpp
(a helices in red, b sheet in yellow) and the
Aspergillus niger phytase PhyA (Oakley, 2010)
(a helices in cyan, b sheet in blue) both taken from
their complexes with the InsP6 analog, InsS6. The
core a+b and capping a-domains are indicated.
The naming of a helices in the capping domain of
BtMinpp (indicated by a lowercase letter) follows
that suggested for PhyA (Oakley, 2010). The atoms
of the bound substrate analog are shown as sticks.
(B) A stereoview of the superposition of the side
chains of InsS6-binding residues (shown as sticks)
of BtMinpp (carbon atoms colored cyan) and
Aspergillus niger PhyA (carbon atoms colored
green). The residues selected for display form the
primary sites of interaction with InsS6 in both
complexes. The van der Waals surface of InsS6
is shown in gray. Residue labels follow the
numbering for the BtMinpp structure. The leading
character identifies the residue in BtMinpp,
whereas the trailing identifies the corresponding
variant residue found in PhyA. An asterisk (*) in-
dicates the position of the A324D substitution.
Selected binding pockets (S1, S2, S5, and S6) are
indicated, numbered according to corresponding sulfate group on the bound ligand. Pocket S4 is obscured in this orientation by the 6-sulfate group of the ligand.
The interaction distance between a carboxyl group oxygen of residue E325 and the bridging ether oxygen of the S3 sulfate group of InsS6 is 3.3 A˚ and is indicated
by a dashed line.
(C) Predicted binding modes within 1 kcal mol-1 of the minimum binding energy resulting from molecular docking experiments for InsP6 with PhyA (left, three
modes) and BtMinpp (right, seven modes). Selected active site residues are shown as sticks and labeled as are binding pockets S2 and S3. The enzyme
molecular surfaces are shown in gray.
(D) View of a ConSurf (Landau et al., 2005) color-coded surface representation of BtMinpp. The normalized conservation scores calculated by ConSurf are a
relative measure of evolutionary conservation at each residue position based on the alignment of 23 MINPP sequences. The highest scores (8 and 9 on the
ConSurf scale) represent the most conserved residue positions and are shown colored blue. The residues with the lowest scores (i.e., the most variable) are
colored red. The bound InsS6 ligand is shown in stick format.but retained the ability to attack the 5- and 1/3-positions (Fig-
ure 1C, inset). Thus, our mutagenic data confirm that the posi-
tional flexibility of BtMinpp toward InsP6 reflects a larger and
less discriminating active site compared to phyA. The R183D
mutant was also about 10-fold less active than wild-type enzyme
(compare Figures 1A and 1C), suggesting that increased cata-
lytic activity may be an evolutionary advantage of BtMinpp’s
more flexible active site.
Given that humanMINPP1 and BtMinpp share a common abil-
ity to attack InsP6 substrate at different positions and remove a
3-phosphate from Ins(1,3,4,5)P4 (see above), we considered
whether our crystallographic analysis of BtMinpp offers an
explanation of the substrate specificity of mammalian MINPPs.
Analysis of the conservation of residues that are predicted to
contribute atoms to the molecular surface of 23 representative
MINPP enzymes from different kingdoms of life reveals highest
sequence identity in a region of the active site centered on H59
(Figure 3D). There is 52% sequence identity between human
MINPP1 and BtMinpp for those active site residues that have
an atom within 8 A˚ of the InsS6 bound to the bacterial enzyme.
Interestingly, residue A31, forming part of binding pocket S5 in
BtMinpp, is commonly replaced with a lysine in other MINPP
enzymes (Figure S5). Introduction of a lysine residue may allow
additional polar contacts with highly negatively charged sub-
strates. Its size may also serve to make binding pocket S5650 Cell Reports 6, 646–656, February 27, 2014 ª2014 The Authorssmaller. This substitution may therefore be of relevance in ex-
plaining the differential activity of Bacteroides and eukaryotic
enzymes toward lower inositol phosphate substrates by enforc-
ing more positional specificity on the mammalian enzyme.
The MINPP Protein Family Includes Microbial Members
Having definedMinpp as a bacterial product, we next performed
a phylogenetic analysis to determine how widespread is the dis-
tribution of minpp homologs in microbial organisms. A BLASTP
search of BtMinpp encoded protein sequence against the nonre-
dundant protein database identified 326 sequences with signifi-
cant alignments (e value% 13 104 and aminimal number of 60
identical amino acids over the entire sequence length). These
included proteins of bacterial, animal, and plant origin. Whereas
most bacterial phyla were represented, no representative of the
Firmicutes, a major phylum of the human GI tract microbiota,
was included. Nevertheless, a significant number of the other
dominant GI-resident organisms (Bacteroides, Bifidobacterium,
Prevotella, and Alistipes) encode proteins belonging to the
MINPP family. In contrast, a search for microbial genes pre-
dicted to encode microbial phytase enzymes among 341 ge-
nomes of the human GI tract (Human Microbiome Project at
http://commonfund.nih.gov/hmp/index) revealed that microbial
phytases are scarce in this environment and are only present
in the genome of subdominant bacterial species (Table S5).
Figure 4. The MINPP Family Phylogenetic Tree
A phylogenetic tree derived from the alignment of 54 MINPP protein representatives from different kingdoms of life was constructed using the Maximum
Likelihood method. The different kingdoms have been assigned the following background colors: animals, blue; plants, green; protists, salmon-pink; bacteria,
yellow. Ac, Acinetobacter; Bac, Bacteroides; Bu, Burkholderia; Bifid, Bifidobacterium. The tree is drawn to scale, with branch lengths measured in the number of
substitutions per site.This analysis leads us to conclude that bacterial Minpps are the
major representative of InsP6-degrading enzymes within the GI
tract of humans and are encoded by dominant bacterial species
that are niche-adapted human symbionts.
A phylogenetic tree (Figure 4) was constructed from the align-
ment of 54 representatives (Table S6) of different kingdoms of
life. In general, MINPP-related sequences are found within the
bacteria, plant, and animal kingdoms with the sequences in
plants and animals being evolutionarily conserved within their
respective clade. However, in the bacterial group, the Bacteroi-
detes phylum does not group with the Actinobacteria phylum as
previously reported (Ciccarelli et al., 2006). The different MinppsCfrom the bacterial species displayed in the tree all appear equally
related to their eukaryotic homologs (Figure 4) with the eukary-
otic and bacterial proteins each forming monophyletic groups,
suggesting an ancient origin for the MINPP family of proteins.
Among the 2,536 completed bacterial genomes listed in
EMBL-EBI (http://www.ebi.ac.uk/genomes/bacteria.html), only
55 contained one or more copies of a gene homologous to
BtMinpp, accounting for 2.2% of the completed genomes. In
contrast, greater than 50% of animal and plant completed
genomes contained at least one copy of a gene predicted to
encode a MINPP representative. Our phylogenetic analyses
strengthen the conclusion from our biochemical and structuralell Reports 6, 646–656, February 27, 2014 ª2014 The Authors 651
(legend on next page)
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studies (see above) that the bacterial Minpp-related protein se-
quences constitute a different family, distinct from phytases,
but nevertheless a subset of clade 2 of the histidine phosphatase
superfamily (HAP; IPR000560) (Rigden, 2008).
InsP6 Metabolism by BtMinpp Secreted from
B. thetaiotaomicron in Outer Membrane Vesicles
The key question of how BtMinpp in the gut survives a hostile
protease-containing environment yet accesses extracellular
InsP6 was addressed. BtMinpp is predicted to contain an N-ter-
minal signal peptide (http://www.cbs.dtu.dk/services/SignalP/),
so we hypothesized that the protein would be secreted into
the periplasmic space. Indeed, the periplasmic fraction of
B. thetaiotaomicron showed substantial Minpp activity (Fig-
ure 5A). This observation led us to investigate if BtMinpp might
also be packaged into outer membrane vesicles (OMVs).
Although OMV blebbing from the cell surface has been observed
in differentBacteroides species,B. fragilis is the only example for
which various enzymatic activities in OMVs have previously been
assayed (Patrick et al., 1996). Transmission electron microscopy
confirmed the presence of membrane blebs and the release of
intact OMVs by B. thetaiotaomicron (Figure 5A). Substantial
InsP6 phosphatase activity was detected in OMV protein ex-
tracts (Figure 5A).
We prepared the protein fraction from the cytoplasm, peri-
plasm and OMVs of a strain of B. thetaiotaomicron from which
we had deleted theminpp gene. All of these fractions had negli-
gible InsP6 phosphatase activity (Figure 5A), indicating that
BtMinpp accounts for the InsP6 phosphatase activity observed
in the corresponding fractions prepared from the wild-type strain
(Figure 5A). Expression ofminpp in trans in the mutant increased
the activity to levels higher than in the wild-type parental strain
in each of the subcellular fractions (Figure 5A). It is noteworthy
that no InsP6 hydrolysis activity was detected in another
human gut Bacteroides species, B. fragilis, that does not contain
a gene related to minpp. In contrast, high levels of InsP6 phos-
phatase activity were detected in the periplasm and OMVs of
B. xylanisolvens (Figure 5A), which contains three copies of the
minpp gene.
We next investigated the capacity of intact vesicles containing
BtMinpp to degrade InsP6 in the external milieu. InsP6 was hy-
drolyzed by OMVs produced and isolated from the wild-typeFigure 5. Intact OMVs Produced by B. thetaiotaomicron Degrade Exog
(A) Minpp activity was assessed in different fractions of B. thetaiotaomicron and
green-based enzyme assay to measure released phosphate. The different fraction
(Bt), Bt minpp-deleted mutant strain GH59 (BtD), and the same strain containing
represent the mean ± SEM values obtained from five to six independent experim
inset showing images of isolated OMVs. Scale bar, 100 nm.
(B) (a) Degradation of InsP6 by intact OMVs produced by B. thetaiotaomicronwild-
containing the pGH037 plasmid overexpressing BtMinpp (BtD (pminpp+). OMVsw
(pminpp+) in a glycine-HCl buffer (pH 2.5) to which InsP6 substrate was added
measured in the buffer fraction of BtD (pminpp+) OMV suspensions after incubati
sonicated extracts of OMVs recovered from the mixtures described in (b). The v
dependent experiments.
(C) Cecal contents were obtained from C57BL/6 mice as described in the Experim
samples from four different mice. InsP6 was added to all samples. (C1) InsP6 c
nonfiltered cecal extract; (C3) cecal extracts filtered (100 kDamolecular weight cu
membrane) and supplemented with OMVs from either a BtMinpp-deleted mutan
Cstrain, whereas no phosphate release from InsP6 was detected
by OMVs produced by the Minpp1-deficient strain (Figure 5B).
We also engineered a B. thetaiotaomicron strain that overex-
presses BtMinpp and recorded between 6 and 12 times more
InsP6 degradation for its isolated OMVs compared to those
from wild-type B. thetaiotaomicron (Figure 5B). The conditioned
media from which OMVs had been removed showed no enzyme
activity; sonication of the OMVs was required for enzyme activity
to be released (Figure 5B). These findings are consistent with
OMVs being intact and that the enzyme is retained in the vesicles
and is not released due to leakage.
The functional significance of this packaging of BtMinpp in
OMVs was investigated in physiological experiments using the
cecal contents of mice to which InsP6 substrate was added
and using HPLC to detect InsP6 metabolites. Note that in these
experiments the commercial InsP6 sample was contaminated
with small peaks of InsP5 (Figure 5C1). Control cecal extracts
contained InsP6-phosphatase activity (Figure 5C2) that was no
longer detected after filtration using a 100 kDa cutoff membrane
(Figure 5C3), capable of removing large protein complexes or
OMVs produced by resident bacteria. In further experiments,
no significant InsP6-phosphatase activity was observed in
filtered cecal extracts supplemented with OMVs prepared from
Minpp-deficient bacteria (Figure 5C4). The assay was also
unable to detect InsP6 phosphatase activity in OMVs produced
by wild-type B. thetaiotaomicron (Figure 5C5), probably due
to limitations in its sensitivity (see Figure 5B). However, when
filtered cecal contents were supplemented with OMVs produced
by B. thetaiotaomicron that overexpress Minpp, considerable
InsP6-phosphatase activity was detected (Figure 5C6). Collec-
tively, these findings demonstrate that BtMinpp is retained
inside the OMVs, which InsP6 must enter in order to access
the BtMinpp.
Minpp1-Loaded Vesicles Induce the Release of
Intracellular Calcium in Colonic Epithelial Cells
It is well established that OMVs produced by bacterial patho-
gens such as Helicobacter pylori, Legionella pneumophila, or
E. coli are capable of interacting with host cells via a membrane
fusion event or via adhesin-receptor-mediated attachment to
deliver virulence factors such as proteases and toxins (Ellis
and Kuehn, 2010). We hypothesized therefore that eitherenous InsP6
other Bacteroides spp. using InsP6 as a substrate and a molybdate/malachite
s were extracted from B. fragilis (Bf), B. xylanisolvens (Bx), B. thetaiotaomicron
the pGH38 plasmid (GH120) expressing BtMinpp (Btcomp). The values shown
ents. The TEM images show Bt cells and associated OMVs (arrowed) with the
type strain (Bt), theminpp-deleted mutant (BtD), and theminpp-deleted mutant
ere isolated, concentrated, and resuspended in a Tris buffer (pH 7.5) and for BtD
and the suspension was incubated for 1 hr at 37C. (b) BtMinpp activity was
on for 1 hr at 37C and removal of OMVs. (c) Enzyme activity was measured in
alues shown represent the mean ± SEM values obtained from at least five in-
ental Procedures. Each HPLC chromatogram panel shown is representative of
ontrol, showing contaminating InsP5s of this commercial InsP6 sample; (C2)
toff membrane); (C4–6) cecal extracts filtered (100 kDamolecular weight cutoff
t (C4), the WT strain (C5), or a strain overexpressing Minpp (C6).
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Figure 6. Minpp1-Loaded Vesicles Modify Colonic Epithelial Cell
Signaling
Fluorescence intensity of Fluo-8 AM-loaded HT29 cells in response to treat-
ment with ionomycin (blue), OMVs from a BtMinpp-deleted mutant (purple),
OMVs containing the overexpressed BtMinpp (red), or PBS alone (green).
The data shown are representative of three experiments, each with three
replicates.mechanism might be used by B. thetaiotaomicron OMVs to
deliver BtMinpp into host intestinal epithelial cells, with the po-
tential consequence that BtMinpp could interact with the inositol
polyphosphate signaling pathways of host cells. Indeed, Yu et al.
(2003) have shown that in mammalian cells expression of an
engineered truncated cytosolic form of the endoplasmic reticu-
lum-confined MINPP1 leads to a significant enhancement of
Ins(1,4,5)P3 concentration, triggering the release of calcium
from intracellular stores via the InsP3 receptor/Ca
2+ channel.
To test these ideas, BtMinpp-containing OMVs were added to
HT29 human colonic epithelial cells in the absence of extracel-
lular calcium. Immediately after addition of the OMVs, a gradual
increase in intracellular calcium concentration was observed
that plateauedwithin approximately 4min (Figure 6). By contrast,
no calcium response was observed when HT29 cells were incu-
bated with OMVs that did not contain any BtMinpp. This result
suggests that OMVs interact with epithelial cells leading to the
release of BtMinpp and generation of InsP3 products. Addition-
ally, it is possible that attachment of OMVs to target cells may
locally increase the concentration of an InsP6 metabolite that
stimulates Ca2+ mobilization. Nevertheless, irrespective of their
mechanism of action, OMVs containing BtMinpp are able,
in vitro, to trigger the release of calcium from intracellular stores
to the cytosol of colonic epithelial cells.
DISCUSSION
The main impact of our study centers on the identification of
a homolog of a eukaryotic inositolphosphate phosphatase,
MINPP, in major species of human gut bacterial genomes.
Detailed biomolecular and phylogenetic analyses of Minpp
from B. thetaiotaomicron (BtMinpp) validated it as a member of
the MINPP family with an exceptionally high catalytic activity
that makes it exquisitely suited for facilitating InsP6 homeostasis
in the mammalian GI tract. Moreover, we rationalize the catalytic
activity and evolutionary conservation of BtMinpp by mutagenic
studies and by an atomic-level description of the structure of this
enzyme at 1.9 A˚ resolution.We further demonstrate that BtMinpp654 Cell Reports 6, 646–656, February 27, 2014 ª2014 The Authorsis packaged inside OMVs, thereby protecting the phosphatase
activity from degradation by gastrointestinal proteases, and
also facilitating an example of cross-kingdom, long-range, cell-
to-cell signaling; we show that the OMVs that are released by
B. thetaiotaomicron are able to deliver BtMinpp to intestinal
epithelial cells, promoting intracellular Ca2+ signaling.
The physiological significance of InsP6 phosphatase activity in
the human gut is likely complex and multifactorial. First, there is
nutritional benefit to both the host and the bacterial community
from the inorganic phosphate and the inositol moiety that are
both released. Additionally, the hydrolysis of InsP6 eliminates
its antinutritive properties, such as divalent ion chelation and in-
hibition of polysaccharide digestibility. High concentrations of
InsP6 have been considered to have anticarcinogenic properties
in the human colon (Fox and Eberl, 2002; Vucenik and Shamsud-
din, 2003). However, a recent paper indicates that lower and
more physiologically relevant levels of InsP6 in the diet might pro-
mote tumor development (Windhorst et al., 2013). This last
finding raises the possibility of further human health impacts of
bacterial Minpp in the GI tract.
B. thetaiotaomicron is a dominant human GI symbiont. More-
over, our phylogenetic studies indicate that the majority of other
bacteria known to harbor aminpp gene are also members of the
human intestinal microbiota. These 149 representatives are from
the Bacteroides, Bifidobacterium, Prevotella, and Alistipes com-
munities. Indeed, our analysis of InsP6 hydrolysis ex vivo from
endogenous cecal contents indicates that the endogenous
enzymatic activity is positionally promiscuous toward its sub-
strates, and contained in OMVs. These are both properties of
BtMinpp making it likely that bacterial Minpps are a widespread
yet hitherto unappreciated source of highly active InsP6 phos-
phatase activity in the GI tract.
Our characterization of the crystal structure of BtMinpp pro-
vides a description of members of the MINPP family at the
atomic level. In particular, the structure of the protein in complex
with InsS6, a substrate analog, gave insight into the reaction
mechanism. We propose that H59 acts as a nucleophile for
cleavage of the 3-phosphate from InsP6, with E325 in an HAE tri-
peptide being the proton donor for the leaving group. Our struc-
tural work also illuminates the positional promiscuity of the
MINPP superfamily, which distinguishes it from the various clas-
ses of phytases in the HAP family that each exhibits a distinct
preference for a particular phosphate group (e.g., 3-phytases,
4/6-phytases, and 5-phytases; Konietzny and Greiner, 2002;
Kumar et al., 2010). Our overlay of the structure of the active
sites of A. niger 3-phytase and BtMinpp revealed that the latter
has a larger and less polar ligand-binding pocket that, according
to our molecular models, accepts InsP6 in several different
orientations (Figure 3C). Furthermore, in a synthetic biology
approach, we mutated R183 in BtMinpp to the corresponding
Arg in the 3-phytase in A. niger. This resulted in BtMinpp losing
the ability to remove the 4/6-phosphate from InsP6 (Figure 1).
That is, the R183D mutation caused the positional preference
of the enzyme to become more phytase-like in nature.
Interestingly, A31 in BtMinpp is commonly replaced with Lys
in other MINPPs (Figure S5), and so this residue may be of
relevance in explaining the differential positional specificities
of Bacteroides and eukaryotic enzymes toward lower inositol
phosphate substrates. For example, the mammalian MINPPs
only removes the 3-phosphate from Ins(1,3,4,5)P4 (Caffrey
et al., 1999), whereas the bacterial enzyme is less selective. It
is an intriguing possibility that a lack of positional selectivity
may be associated with elevated catalytic activity of BtMinpp
against InsP6. Nevertheless, we found a 52% sequence identity
between human MINPP1 and BtMinpp for those active site res-
idues that have an atomwithin 8 A˚ of the InsS6 that cocrystallized
in the active site. Such a high degree of evolutionary conserva-
tion would suggest that bacterial and mammalian Minpps have
originated from a common primordial ancestor. It is alternately
possible that bacteria acquired Minpps from eukaryotes by
horizontal gene transfer (HGT), although known cases of this
phenomenon are rare (Keeling and Palmer, 2008). Our phyloge-
netic analyses were unable to distinguish between these two
alternatives.
Our characterization of the properties of a vesicularized bacte-
rial homolog of a mammalian signaling enzyme challenges
established orthodoxies concerning our understanding of the
mechanisms by which symbiotic bacteria in the mammalian GI
tract interact with their host. First, it has been thought that
OMVs primarily mediate pathogenic processes (Ellis and Kuehn,
2010). Our data reveal that commensal gut bacteria also utilize
OMVs in a manner that is beneficial to the host, by contributing
to InsP6 homeostasis. The ability of BtMinpp-containing OMVs
to stimulate intracellular Ca2+ release in human colonic epithelial
cells suggests a further biological significance to bacterial
Minpps, namely, a role in interkingdom communication path-
ways (Figure 6). Another example of this phenomenon is the
OMV-mediated delivery of immunoregulatory capsular polysac-
charide A from B. fragilis to host dendritic cells to effect disease
protection (Shen et al., 2012). Nevertheless, the application of an
enzyme to mediate dialog between gut bacteria and the human
host is an addition to a field of research that has previously
focused on the roles of diffusible, small-molecule hormones
and nutrients. Further research into variations in the expression
and secretion of Minpps by the different species of GI bacteria
could increase our insight into the complex interrelationships
between the microbiome and the human host.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
All E. coli and Bacteroides strains used in this study are listed in Table S7. The
bacterial growth conditions are described in the Supplemental Information.
HPLC
Inositol phosphate products of assays using 32P-labeled substrate were
resolved by HPLC, details of which are provided in the Supplemental
Information.
Crystal Structure Determination
A single crystal of selenomethionyl-derivitized BtMinpp was used to collect a
SAD data set, which was processed using the CCP4 package to obtain a
crystal structure as described in the Supplemental Information.
Phylogenetic Analysis
The evolutionary history of theMINPP protein was inferred using theMaximum
Likelihood method in the MEGA5 software tool (Tamura et al., 2011). Amino
acid sequences were alignedwith PRANK and highly variable regions removedCfrom the data set. The Whelan and Goldman (2001) model of evolution was
used, and initial tree(s) for the heuristic search was obtained automatically
as follows. When the number of common sites was <100 or less than one-
fourth of the total number of sites, the maximum parsimony method was
used; otherwise, BIONJ method with MCL distance matrix was used. To pro-
vide statistical support for each node on the tree, a consensus tree was gener-
ated from 1,000 bootstrap data sets.
Periplasmic and OMV Protein Extraction and BtMinpp Phosphatase
Activity Measurement
The method of Osborn et al. (1972) was used to obtain periplasmic fractions of
B. thetaiotaomicron andOMVswere harvested frombacterial cultures by ultra-
centrifugation and assayed for phosphatase activity using the PiColorLock
Gold Phosphate Detection System as described in the Supplemental
Information.
Intracellular Calcium Measurement
HT-29 cells were propagated in Sarstedt culture flasks (25 cm2) in a 5% CO2
humidified atmosphere at 37C. Cells were fed with DMEM (Lonza) supple-
mented with 10% heat-inactivated FBS (Biosera) and 2 mM L-glutamine
(Lonza). For the intracellular calcium measurement assay, cells were seeded
in 24-well microplates (Corning CellBind Surface) at a density of 105 cells/
well. After 16 hr, the culture medium was replaced with fresh medium contain-
ing 5 mM of the calcium indicator Fluo-8 AM (AAT Bioquest), 4 mM of Proben-
ecid (Sigma-Aldrich), and 0.025% (w/v) Pluronic acid F-127 (Invitrogen)
according to a method adapted from Abrahamse and Rechkemmer, 2001,
and cells were incubated for 30 min at 37C, 5% CO2. The medium was
removed, and calcium-free PBS was added before the cells were incubated
at 37C for another 30 min. The cell monolayer was washed twice with
calcium-free PBS and PBS was added. Fluo-8 fluorescence was measured
immediately after addition of Ionomycin (Sigma-Aldrich) 1 mg/ml, PBS, or
purified OMVs (corresponding to 10 mg of soluble protein) with a FLUOstar
Optima fluorescence plate reader (BMG Labtechnologies) fitted with custom
excitation/emission filters (485/538 nm). OMVs were purified from 500 ml cul-
ture supernatants, washed with calcium-free PBS, and concentrated to a 2 ml
suspension.
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